These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10590682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.
    Kitchen S, Iampietro R, Woolley AM, Preston FE.
    Thromb Haemost; 1999 Oct; 82(4):1289-93. PubMed ID: 10544915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 6. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J, Haaf B, Dempfle CE, Stehle G, Heene DL.
    Nephrol Dial Transplant; 1995 Feb; 10(2):217-22. PubMed ID: 7753456
    [Abstract] [Full Text] [Related]

  • 7. Monitoring low molecular weight heparins.
    Garon JE.
    Clin Leadersh Manag Rev; 2003 Feb; 17(1):47-50. PubMed ID: 12592880
    [Abstract] [Full Text] [Related]

  • 8. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R, Grebe S.
    Res Vet Sci; 2000 Dec; 69(3):241-7. PubMed ID: 11124095
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J.
    J Mal Vasc; 1987 Dec; 12 Suppl B():68-70. PubMed ID: 2834495
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.
    Kristensen HI, Ostergaard PB, Nordfang O, Abildgaard U, Lindahl AK.
    Thromb Haemost; 1992 Sep 07; 68(3):310-4. PubMed ID: 1332210
    [Abstract] [Full Text] [Related]

  • 15. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
    Calatzis A, Peetz D, Haas S, Spannagl M, Rudin K, Wilmer M.
    Am J Clin Pathol; 2008 Sep 07; 130(3):446-54. PubMed ID: 18701419
    [Abstract] [Full Text] [Related]

  • 16. [Biological monitoring of treatment with low molecular weight heparin].
    Aiach M, Sié P.
    Ann Biol Clin (Paris); 1988 Sep 07; 46(9):715-8. PubMed ID: 2851948
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood.
    Harenberg J, Giese C, Dempfle CE, Stehle G, Heene DL.
    Thromb Haemost; 1988 Dec 22; 60(3):377-81. PubMed ID: 2853458
    [Abstract] [Full Text] [Related]

  • 18. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD, Brandenburg VM, Lanzmich R, Floege J.
    Nephrol Dial Transplant; 2004 Jun 22; 19(6):1552-8. PubMed ID: 15034159
    [Abstract] [Full Text] [Related]

  • 19. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ, Shi XB, Yang JG, Hu DY.
    Chin Med J (Engl); 2009 May 20; 122(10):1199-202. PubMed ID: 19493471
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.